OncoMed Pharmaceuticals Reports Second Quarter 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. SPY
5. META
6. MSFT
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to OncoMed Pharmaceuticals Reports Second Quarter 2016 Financial Results

OncoMed Pharmaceuticals (OMED) PT Raised to $16 at Jefferies

August 10, 2016 8:31 AM EDT

Jefferies analyst Brian Abrahams reiterated a Buy rating and boosted his price target on OncoMed Pharmaceuticals (NASDAQ: OMED) to $16.00 (from $15.00) following Q2 update.

Abrahams commented, "OMED will have multiple data updates in 2H16/1H17 as well as potential opt-in catalysts from collaborators. We... More

OncoMed Pharma (OMED) Misses Q2 EPS by 10c

August 9, 2016 5:09 PM EDT

OncoMed Pharma (NASDAQ: OMED) reported Q2 EPS of ($0.91), $0.10 worse than the analyst estimate of ($0.81). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $8.09 million.

For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.

... More